Used in biomedical research to quantify receptor activator of nuclear factor kappa-B ligand (RANKL) in rat samples, this ELISA kit helps investigate bone metabolism, osteoporosis, and inflammatory diseases. It enables accurate measurement of RANKL levels in serum, plasma, or cell culture supernatants, supporting studies on bone remodeling, arthritis, and immune-bone interactions. The assay is widely applied in preclinical research to evaluate therapeutic targets and monitor disease progression in rodent models.